Weight loss drugs are getting people to the doctor. Now comes the wave of long-ignored diagnoses

Weight loss drugs are getting people to the doctor. Now comes the wave of 
long-ignored diagnoses

Demand for weight loss drugs like Ozempic is also boosting diagnoses of conditions such as sleep apnea and cardiovascular disease.
7 hours ago
from: Quartz

Continue reading...
Anti-obesity medication, GLP-1 receptor agonist, Health care, Obesity, Semaglutide, Weight loss
More about this
- Future of Obesity Care: 3 Wishes from Thought Leader Donna Ryan, MD
When asked about her 3 wishes for the future of obesity care, Donna Ryan, MD, told Patient Care that she had just one: access.
from: Patient Care Online
- Growth, Volume, Price: The Skinny on GLP-1 Medications
For the 40% of American adults with obesity, glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, may offer hope—but the cost can put...
from: National Conference of State Legislatures
- Do the new weight-loss drugs improve your health?
The FDA has approved three GLP-1 receptor agonist drugs for weight loss. The drugs not only lower blood sugar and weight, but also reduce...
from: Harvard Health
- Mindy Grupe - Non-Surgical Weight Loss, Patient Story
Mindy Grupe wanted to lose at least 100 pounds to overcome her health problems. Yet, bariatric surgery seemed a more extreme step than she...
from: MercyOne
- Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related...
from: Hawaii Tribune-Herald
- Weight loss drugs like Ozempic, Wegovy are all the rage. Are they safe for kids?
The Dallas Morning News. DALLAS — Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to...
from: The Daily Item
- Can weight loss drugs reduce healthcare costs?
In today's Finshots, we explore how weight loss drugs are being touted as a way to cut healthcare costs in the US and whether they really...
from: Finshots
- Weight loss drugs are getting people to the doctor. Now comes the wave of long-ignored diagnoses
Popular weight-loss drugs like Wegovy and Zepbound are boosting the use of healthcare in the U.S., leading to an uptick in patients getting...
from: Yahoo
- Expert Perspectives 2024: The Dynamic Future of Obesity Medicine, with Donna Ryan, MD
The future of obesity medicine is filled with promise as GLP-1 RAs and other peptides continue to demonstrate pluripotency in metabolic...
from: Patient Care Online